| Literature DB >> 104005 |
B Sharf, C Moskovitz, M D Lupton, H L Klawans.
Abstract
Twenty-seven of eighty-eight (30.7%) Parkinsonian patients on chronic levodopa or levodopa/carbidopa therapy developed drug related dream phenomena. The patients reported three separate types of new dreams which we have classified as vivid dreams, night terrors and nightmares. These dreams are correlated to the duration of levodopa therapy although the mechanism of their production is unclear.Entities:
Mesh:
Substances:
Year: 1978 PMID: 104005 DOI: 10.1007/bf01579073
Source DB: PubMed Journal: J Neural Transm Impact factor: 3.575